CVS Health Corporation (CVS) is a Medical - Healthcare Plans company in the Healthcare sector, currently trading at $77.62. It has a SharesGrow Score of 55/100, indicating a above average investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CVS = $445.93 (+474.5% from the current price, the stock appears undervalued). Analyst consensus target is CVS = $95 (+21.7% upside).
Valuation: CVS trades at a trailing Price-to-Earnings (P/E) of 57 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 4.13.
Financials: revenue is $402.1B, +7.7%/yr average growth. Net income is $1.8B, growing at -4.3%/yr. Net profit margin is 0.4% (thin). Gross margin is 13.8% (-3.1 pp trend).
Balance sheet: total debt is $93.6B against $75.2B equity (Debt-to-Equity (D/E) ratio 1.24, moderate). Current ratio is 0.84 (tight liquidity). Debt-to-assets is 35.9%. Total assets: $261.1B.
Analyst outlook: 35 / 41 analysts rate CVS as buy (85%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 45/100 (Partial), Growth 40/100 (Partial), Past 100/100 (Pass), Health 33/100 (Fail), Moat 51/100 (Partial), Future 88/100 (Pass), Income 30/100 (Fail).
